Literature DB >> 18180426

Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America.

Tyrone D Cannon1, Kristin Cadenhead, Barbara Cornblatt, Scott W Woods, Jean Addington, Elaine Walker, Larry J Seidman, Diana Perkins, Ming Tsuang, Thomas McGlashan, Robert Heinssen.   

Abstract

CONTEXT: Early detection and prospective evaluation of individuals who will develop schizophrenia or other psychotic disorders are critical to efforts to isolate mechanisms underlying psychosis onset and to the testing of preventive interventions, but existing risk prediction approaches have achieved only modest predictive accuracy.
OBJECTIVES: To determine the risk of conversion to psychosis and to evaluate a set of prediction algorithms maximizing positive predictive power in a clinical high-risk sample. DESIGN, SETTING, AND PARTICIPANTS: Longitudinal study with a 2 1/2-year follow-up of 291 prospectively identified treatment-seeking patients meeting Structured Interview for Prodromal Syndromes criteria. The patients were recruited and underwent evaluation across 8 clinical research centers as part of the North American Prodrome Longitudinal Study. MAIN OUTCOME MEASURE: Time to conversion to a fully psychotic form of mental illness.
RESULTS: The risk of conversion to psychosis was 35%, with a decelerating rate of transition during the 2 1/2-year follow-up. Five features assessed at baseline contributed uniquely to the prediction of psychosis: a genetic risk for schizophrenia with recent deterioration in functioning, higher levels of unusual thought content, higher levels of suspicion/paranoia, greater social impairment, and a history of substance abuse. Prediction algorithms combining 2 or 3 of these variables resulted in dramatic increases in positive predictive power (ie, 68%-80%) compared with the prodromal criteria alone.
CONCLUSIONS: These findings demonstrate that prospective ascertainment of individuals at risk for psychosis is feasible, with a level of predictive accuracy comparable to that in other areas of preventive medicine. They provide a benchmark for the rate and shape of the psychosis risk function against which standardized preventive intervention programs can be compared.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18180426      PMCID: PMC3065347          DOI: 10.1001/archgenpsychiatry.2007.3

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  59 in total

1.  Pathogenesis of schizophrenia: a psychopathological perspective.

Authors:  D G Cunningham Owens; Patrick Miller; Stephen M Lawrie; Eve C Johnstone
Journal:  Br J Psychiatry       Date:  2005-05       Impact factor: 9.319

Review 2.  Obesity--a critical issue in preventive cardiology: the Bogalusa Heart Study.

Authors:  Gerald S Berenson
Journal:  Prev Cardiol       Date:  2005

3.  The family history method using diagnostic criteria. Reliability and validity.

Authors:  N C Andreasen; J Endicott; R L Spitzer; G Winokur
Journal:  Arch Gen Psychiatry       Date:  1977-10

Review 4.  Early detection and intervention with schizophrenia: rationale.

Authors:  T H McGlashan; J O Johannessen
Journal:  Schizophr Bull       Date:  1996       Impact factor: 9.306

5.  DSM-III-R schizotypal personality traits in offspring of schizophrenic disorder, affective disorder, and normal control parents.

Authors:  E Squires-Wheeler; A E Skodol; A Bassett; L Erlenmeyer-Kimling
Journal:  J Psychiatr Res       Date:  1989       Impact factor: 4.791

6.  Diagnosing schizophrenia in the initial prodromal phase.

Authors:  J Klosterkötter; M Hellmich; E M Steinmeyer; F Schultze-Lutter
Journal:  Arch Gen Psychiatry       Date:  2001-02

7.  Social competence deficits in adolescents at risk for schizophrenia.

Authors:  R H Dworkin; J A Lewis; B A Cornblatt; L Erlenmeyer-Kimling
Journal:  J Nerv Ment Dis       Date:  1994-02       Impact factor: 2.254

8.  Mental disorders in first-degree relatives of schizophrenics.

Authors:  S Onstad; I Skre; J Edvardsen; S Torgersen; E Kringlen
Journal:  Acta Psychiatr Scand       Date:  1991-06       Impact factor: 6.392

9.  An independent analysis of the Copenhagen sample of the Danish adoption study of schizophrenia. II. The relationship between schizotypal personality disorder and schizophrenia.

Authors:  K S Kendler; A M Gruenberg; J S Strauss
Journal:  Arch Gen Psychiatry       Date:  1981-09

10.  The "close-in" or ultra high-risk model: a safe and effective strategy for research and clinical intervention in prepsychotic mental disorder.

Authors:  Patrick D McGorry; Alison R Yung; Lisa J Phillips
Journal:  Schizophr Bull       Date:  2003       Impact factor: 9.306

View more
  471 in total

1.  Premorbid multivariate markers of neurodevelopmental instability in the prediction of adult schizophrenia-spectrum disorder: a high-risk prospective investigation.

Authors:  Shana Golembo-Smith; Jason Schiffman; Emily Kline; Holger J Sørensen; Erik L Mortensen; Laura Stapleton; Kentaro Hayashi; Niels M Michelsen; Morten Ekstrøm; Sarnoff Mednick
Journal:  Schizophr Res       Date:  2012-06-02       Impact factor: 4.939

2.  Longitudinal changes in cortisol secretion and conversion to psychosis in at-risk youth.

Authors:  Elaine F Walker; Patricia A Brennan; Michelle Esterberg; Joy Brasfield; Brad Pearce; Michael T Compton
Journal:  J Abnorm Psychol       Date:  2010-05

3.  Abnormal movements are associated with poor psychosocial functioning in adolescents at high risk for psychosis.

Authors:  Vijay A Mittal; Maria Jalbrzikowski; Melita Daley; Cristina Roman; Carrie E Bearden; Tyrone D Cannon
Journal:  Schizophr Res       Date:  2011-06-01       Impact factor: 4.939

4.  Is the Gly82Ser polymorphism in the RAGE gene relevant to schizophrenia and the personality trait psychoticism?

Authors:  Petra Suchankova; Jonas Klang; Carin Cavanna; Göran Holm; Staffan Nilsson; Erik G Jönsson; Agneta Ekman
Journal:  J Psychiatry Neurosci       Date:  2012-02       Impact factor: 6.186

5.  Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis.

Authors:  Larry J Seidman; Anthony J Giuliano; Eric C Meyer; Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Thomas H McGlashan; Diana O Perkins; Ming T Tsuang; Elaine F Walker; Scott W Woods; Carrie E Bearden; Bruce K Christensen; Keith Hawkins; Robert Heaton; Richard S E Keefe; Robert Heinssen; Barbara A Cornblatt
Journal:  Arch Gen Psychiatry       Date:  2010-06

6.  Psychosis risk screening with the Prodromal Questionnaire--brief version (PQ-B).

Authors:  Rachel L Loewy; Rahel Pearson; Sophia Vinogradov; Carrie E Bearden; Tyrone D Cannon
Journal:  Schizophr Res       Date:  2011-04-20       Impact factor: 4.939

7.  Using biomarkers to inform diagnosis, guide treatments and track response to interventions in psychotic illnesses.

Authors:  Veronica B Perez; Neal R Swerdlow; David L Braff; Risto Näätänen; Gregory A Light
Journal:  Biomark Med       Date:  2014       Impact factor: 2.851

8.  Childhood trauma and prodromal symptoms among individuals at clinical high risk for psychosis.

Authors:  Judy L Thompson; Meredith Kelly; David Kimhy; Jill M Harkavy-Friedman; Shamir Khan; Julie W Messinger; Scott Schobel; Ray Goetz; Dolores Malaspina; Cheryl Corcoran
Journal:  Schizophr Res       Date:  2009-01-25       Impact factor: 4.939

9.  Identifying a treatable psychosis-risk cohort.

Authors:  Jean Addington
Journal:  Can J Psychiatry       Date:  2013-01       Impact factor: 4.356

Review 10.  Converging levels of analysis on a genomic hotspot for psychosis: insights from 22q11.2 deletion syndrome.

Authors:  Matthew J Schreiner; Maria T Lazaro; Maria Jalbrzikowski; Carrie E Bearden
Journal:  Neuropharmacology       Date:  2012-10-23       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.